Correlation Between Medigen Vaccine and SYN Tech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Medigen Vaccine and SYN Tech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Medigen Vaccine and SYN Tech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Medigen Vaccine Biologics and SYN Tech Chem Pharm, you can compare the effects of market volatilities on Medigen Vaccine and SYN Tech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Medigen Vaccine with a short position of SYN Tech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Medigen Vaccine and SYN Tech.

Diversification Opportunities for Medigen Vaccine and SYN Tech

-0.4
  Correlation Coefficient

Very good diversification

The 3 months correlation between Medigen and SYN is -0.4. Overlapping area represents the amount of risk that can be diversified away by holding Medigen Vaccine Biologics and SYN Tech Chem Pharm in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SYN Tech Chem and Medigen Vaccine is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Medigen Vaccine Biologics are associated (or correlated) with SYN Tech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SYN Tech Chem has no effect on the direction of Medigen Vaccine i.e., Medigen Vaccine and SYN Tech go up and down completely randomly.

Pair Corralation between Medigen Vaccine and SYN Tech

Assuming the 90 days trading horizon Medigen Vaccine Biologics is expected to under-perform the SYN Tech. In addition to that, Medigen Vaccine is 2.02 times more volatile than SYN Tech Chem Pharm. It trades about -0.03 of its total potential returns per unit of risk. SYN Tech Chem Pharm is currently generating about 0.06 per unit of volatility. If you would invest  8,011  in SYN Tech Chem Pharm on November 5, 2024 and sell it today you would earn a total of  1,259  from holding SYN Tech Chem Pharm or generate 15.72% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Medigen Vaccine Biologics  vs.  SYN Tech Chem Pharm

 Performance 
       Timeline  
Medigen Vaccine Biologics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
OK
Over the last 90 days Medigen Vaccine Biologics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly abnormal basic indicators, Medigen Vaccine showed solid returns over the last few months and may actually be approaching a breakup point.
SYN Tech Chem 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days SYN Tech Chem Pharm has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, SYN Tech is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Medigen Vaccine and SYN Tech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Medigen Vaccine and SYN Tech

The main advantage of trading using opposite Medigen Vaccine and SYN Tech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Medigen Vaccine position performs unexpectedly, SYN Tech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SYN Tech will offset losses from the drop in SYN Tech's long position.
The idea behind Medigen Vaccine Biologics and SYN Tech Chem Pharm pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.

Other Complementary Tools

Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios